Principal Financial Group
BSTC

Principal Financial Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Principal Financial Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,351
Closed -$283K – 2487
2020
Q3 		$283K Buy
+5,351
New +$330K ﹤0.01% 2138
2020
Q2 		– Sell
-4,309
Closed -$244K – 2391
2020
Q1 		$244K Buy
4,309
+18
+0.4% +$1.03K ﹤0.01% 2020
2019
Q4 		$244K Buy
+4,291
New +$227K ﹤0.01% 2092

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Principal Financial Group's BSTC Position: Q4 2020 in Review

Principal Financial Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 5,351 shares — an estimated $283K sold.

Principal Financial Group first reported a position in BSTC in Q4 2019 and held it in 3 quarters. The position peaked at $283K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Principal Financial Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Principal Financial Group sold 5,351 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $283K.
  • Principal Financial Group first reported a position in BioSpecifics Technologies Corp. in Q4 2019 and held it in 3 quarters.
  • Principal Financial Group's BioSpecifics Technologies Corp. position peaked at $283K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Principal Financial Group's 13F filing for Q4 2020, filed 8 Feb 2021.